Agios Pharma (AGIO) Announces Proposed Offering of Common Stock

Agios Pharmaceuticals, Inc. (Nasdaq: AGIO) today announced that it is offering to sell, subject to market and other conditions, up to 7.5 million shares of its common stock in an underwritten public offering. Agios also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock sold in the public offering. All of the shares in the offering are to be sold by Agios. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed.

J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and Cowen and Company, LLC are acting as joint book-running managers for the offering.

You May Also Be Interested In

• Treasure Global sells shares in two deals worth $6.6M total
• Agios Pharma (AGIO) Reiterated at Overweight by Cantor Fitzgerald on Thalassemia Opportunity
• Divcon adds data center veteran Tom Ray to its board